CA - Aptose Biosciences Inc. (APTO) Q1 2024 Earnings Call Transcript

2024-05-14 23:12:06 ET

Aptose Biosciences Inc. (APTO)

Q1 2024 Earnings Conference Call

May 14, 2024 05:00 PM ET

Company Participants

Susan Pietropaolo - MD, Corporate Communications and IR

William Rice - Chairman, President and CEO

Rafael Bejar - SVP and CMO

Fletcher Payne - SVP, CFO, and CBO

Conference Call Participants

Joe Pantginis - H.C. Wainwright

Presentation

Operator

Good afternoon. My name is Josh and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences' Conference Call for the First Quarter ended March 31st, 2024. At this time, all participants are in a listen only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. As a reminder, this conference call may be recorded.

I would like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan Pietropaolo

Thank you, Josh. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended March 31st, 2024.

Earlier today, Aptose issued a press release relating to these financial results. The news release as well as related SEC filings are accessible at Aptose's website.

Joining me on today's call are Dr. William Rice, Chairman, President and CEO; Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer and Chief Business Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian Securities laws.

Forward-looking statements reflect Aptose's current expectations regarding future events. They are not guarantees of performance and it is possible that actual results and performance could differ materially these stated expectations. They involve known and unknown risks, uncertainties, and assumptions that may cause actual results, performance, and achievement to differ materially from those expressed....

For further details see: